logo
logo

Rejuvenate Bio Receives $4M Grant from California Institute for Regenerative Medicine (CIRM) for RJB-0402 Development

Rejuvenate Bio Receives $4M Grant from California Institute for Regenerative Medicine (CIRM) for RJB-0402 Development

07/01/24, 12:01 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan diego
Money raised
$4 million
Industry
biotechnology
health care
Investors
California Institute For Regenerative Medicine (Cirm)
Rejuvenate Bio has received a $4M grant from the California Institute for Regenerative Medicine (CIRM) to complete IND-enabling activities for the development of RJB-0402, a novel gene therapy for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM).

Company Info

Company
Rejuvenate Bio
Location
san diego, california, united states
Additional Info
Rejuvenate Bio is a biotechnology company dedicated to developing novel gene therapies for chronic age-related diseases.

Related People